Phase II testing of Xenon International on Mount Schauinsland, Germany.

Station RN33 on Mount Schauinsland near Freiburg, Germany, is part of the International Monitoring System monitoring radioxenon in air (131mXe, 133Xe, 133mXe, and 135Xe) for verification of the Comprehensive Nuclear Test Ban Treaty. Here, we present data from phase II testing of a new system, Xenon International at RN33, July 14th, 2021 to Jan 22nd, 2022, together with SPALAX data from the same time period. Radioxenon could be detected in 473 of 719 samples, among them many multiple isotope detections. Activity concentrations of spiked and selected environmental samples were verified by laboratory reanalysis. The sensitivity of Xenon International for radioxenons is up to one order of magnitude better for the metastable isotopes than that of the SPALAX, with a shorter sampling duration of 6 h.

Building the bridge between U(VI) and Ca-bentonite - Influence of concentration, ionic strength, pH, clay composition and competing ions.

In the context of a high-level nuclear waste disposal, the retention of U(VI) on non-pre-treated Ca-bentonite as potential technical barrier is studied. The objective of this study is to reveal the retention behaviour of U(VI) under extreme geochemical conditions, such as hyperalkaline pH range as well as high salinity at the same time, and taking into account other relevant parameters. This should lead to a better understanding of necessary safety precautions for avoiding a release of U(VI) in the environment. Batch experiments were conducted to determine the influence of the initial U(VI) concentration, salinity, pH value, clay composition and the presence of other elements (Ca(II), I-, Cs(I), Eu(III)). After the sorption experiments, the remaining U(VI) concentration in solution was determined via mass spectrometry with inductively coupled plasma. U(VI) can be immobilised from 10% to 100% under all investigated conditions. Precipitation plays a role in the U(VI) retention but only at higher concentrations (≥10-5 mol L-1). The retention is reversible especially with decreasing pH (<10.5) as the aquo complex Ca2UO2(CO3)3(aq) is formed. Ca(II) strongly enhances the U(VI) adsorption onto Ca-bentonite in the hyperalkaline pH range, probably due to the formation of Ca(II)-bridges. The best retention could be observed on natural bentonite compared to pure montmorillonite and altered bentonite. From a waste cocktail containing important elements of the repository inventory (Cs(I), Eu(III), U(VI) and iodide), only Eu(III) as homologous element to trivalent actinoids competes with U(VI) for binding sites, especially at low metal concentrations, but also facilitates the precipitation at higher concentrations.

Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma.

Tumor heterogeneity is considered to be a hallmark of glioblastoma (GBM). Only more recently, it has become apparent that GBM is not only heterogeneous between patients (intertumoral heterogeneity) but more importantly, also within individual patients (intratumoral heterogeneity). In this study, we focused on assessing intratumoral heterogeneity. For this purpose, the heterogeneity of 38 treatment-naïve GBM was characterized by immunohistochemistry. Perceptible areas were rated for ALDH1A3, EGFR, GFAP, Iba1, Olig2, p53, and Mib1. By clustering methods, two distinct groups similar to subtypes described in literature were detected. The classical subtype featured a strong EGFR and Olig2 positivity, whereas the mesenchymal subtype displayed a strong ALDH1A3 expression and a high fraction of Iba1-positive microglia. 18 tumors exhibited both subtypes and were classified as "subtype-heterogeneous", whereas the areas of the other tumors were all assigned to the same cluster and named "subtype-dominant". Results of epigenomic analyses corroborated these findings. Strikingly, the subtype-heterogeneous tumors showed a clearly shorter overall survival compared to subtype-dominant tumors. Furthermore, 21 corresponding pairs of primary and recurrent GBM were compared, showing a dominance of the mesenchymal subtype in the recurrent tumors. Our study confirms the prognostic impact of intratumoral heterogeneity in GBM, and more importantly, makes this hallmark assessable by routine diagnostics.

Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma.

BACKGROUND: Glioblastoma (GBM) is the most malignant primary brain tumor. Relapse occurs regularly, and the clinical behavior seems to be due to a therapy-resistant subpopulation of glioma-initiating cells that belong to the group of cancer stem cells. Aldehyde dehydrogenase (ALDH) has been identified as a marker for this cell population, and we have shown previously that ALDH1A3-positive GBM cells are more resistant against temozolomide (TMZ) treatment. However, it is still unclear how ALDH expression mediates chemoresistance. MATERIALS AND METHODS: ALDH1A3 expression was analyzed in 112 specimens from primary and secondary surgical resections of 56 patients with GBM (WHO grade IV). All patients received combined adjuvant radiochemotherapy. For experimental analysis, CRISPR-Cas9-induced knockout cells from three established GBM cell lines (LN229, U87MG, T98G) and two glioma stem-like cell lines were investigated after TMZ treatment. RESULTS: ALDH1A3 knockout cells were more sensitive to TMZ, and oxidative stress seemed to be the molecular process where ALDH1A3 exerts its role in resistance against TMZ. Oxidative stress led to lipid peroxidation, yielding active aldehydes that were detoxified by ALDH enzymatic activity. During the metabolic process, autophagy was induced leading to downregulation of the enzyme, but ALDH1A3 is upregulated to even higher expression levels after finishing the TMZ therapy in vitro. Recurrent GBMs show significantly higher ALDH1A3 expression than the respective samples from the primary tumor, and patients suffering from GBM with high ALDH1A3 expression showed a shorter median survival time (12 months vs 21 months, P < .05). CONCLUSION: Oxidative stress is an important and clinically relevant component of TMZ-induced therapeutic effects. Cytotoxicity seems to be mediated by aldehydes resulting from lipid peroxidation, and ALDH1A3 is able to reduce the number of toxic aldehydes. Therefore, we present a molecular explanation of the role of ALDH1A3 in therapeutic resistance of human GBM cells.

Surfactant assisted extraction of incidental nanoparticles from road runoff sediment and their characterization by single particle-ICP-MS.

A surfactant assisted extraction (SAE) method was developed to extract incidental nanoparticles (INPs) in the <300 nm particle size fraction from road runoff sediments and applied to a road runoff sediment. The method was evaluated by spiking experiments of road runoff sediment with engineered nanoparticle (ENP) suspensions of gold (Au-ENPs) between 30 nm and 200 nm and platinum (Pt-ENPs) between 30 nm and 70 nm with content ranging from 40 to 800 ng/g. Suspensions were analyzed by single particle (sp-)ICP-MS. In the presence of a road runoff matrix, an increase in ENP sizes by a maximum of 8% for Au-ENPs and 9% for Pt-ENPs was observed. ENPs mass recovery was >50% for all Au-ENPs with content higher than 200 ng/g and for 30 and 50 nm Pt-ENPs at content of 160 ng/g while for lower content the recovery was 0%. For 70 nm Pt-ENPs, recovery was always >80% and increased with increasing Pt content up to 100% in the presence of road runoff matrix. Metal content of INPs in the road runoff sediment in the fraction <300 nm decreased from copper (Cu; µg/g)> zinc (Zn)> zirconium (Zr)> cerium (Ce)> lead (Pb)> cadmium (Cd) > platinum (Pt; µg/g). Over 90% of Pt-, Zn-, Cd-, Pb- and Ce-INPs are composed of particles with less than 20 fg, while Zr- and Cu-INPs are dominated by masses higher than 20 fg. The tested SAE may be applicable to determine environmental contents of INPs in sediments and possibly in soils.